Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis
NCT02581449 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2015-10-21
Summary
The purpose of the study is to evaluate the effect of omega-3 fatty acids supplementation on pediatric patients undergoing hemodialysis via the measurement of the following before and after omega-3 administration:oxidative stress markers, inflammatory markers and serum lipids.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
omega-3
dietary supplement
- OTHER
-
empty soft gelatin capsules
empty softgels of matched size, shape and color
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Ain Shams · university
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
More Related Trials
-
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
NCT01055119 ·Status: COMPLETED ·Phase: NA
-
Effect of DHA on Proinflammatory Cytokines Including Platelets Activating Factor (PAF) in Preterm Neonates
NCT04746885 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children
NCT01547910 ·Status: COMPLETED ·Phase: PHASE2
-
Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging
NCT04910399 ·Status: COMPLETED ·Phase: NA
-
Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans
NCT01317290 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders
NCT01248130 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia
NCT01308710 ·Status: COMPLETED ·Phase: PHASE1
-
Diet Rich in N-3 Polyunsaturated Fatty Acids in Renal Transplant Recipients
NCT01872455 ·Status: COMPLETED ·Phase: PHASE4
-
A Preliminary Study on Effect of Omega-3 on Human Sperm
NCT00479960 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
NCT00382616 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3, Inflammation in ADHD With AI
NCT07348562 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Supplementation on Nutritional Status and Physical Activity of Obese Children
NCT04156971 ·Status: COMPLETED ·Phase: NA
-
Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention
NCT00519779 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD
NCT01795040 ·Status: UNKNOWN ·Phase: NA
-
Omega-3 Fatty Acids Supplementation in ADHD
NCT01777048 ·Status: TERMINATED ·Phase: PHASE3
-
Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD
NCT03542643 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.
NCT03216057 ·Status: COMPLETED ·Phase: NA
-
Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children
NCT01323283 ·Status: COMPLETED ·Phase: NA
-
Enhancement of Learning and Memory Following Supplementation With Juice PLUS+® OMEGA in an Adolescent Population
NCT05581108 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)
NCT02986672 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Supplementation in Cystic Fibrosis Patients
NCT00959010 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition
NCT03245749 ·Status: COMPLETED
-
PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children
NCT00700323 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega3 PUFA in Head Trauam
NCT02762539 ·Status: UNKNOWN ·Phase: NA